Volume | 858,134 |
|
|||||
News | (1) | ||||||
Day High | 1.78 | Low High |
|||||
Day Low | 1.4901 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Clearside Biomedical Inc | CLSD | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.78 | 1.4901 | 1.78 | 1.56 | 1.71 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,975 | 858,134 | $ 1.63 | $ 1,402,972 | - | 0.650101 - 2.12 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:31:07 | 84 | $ 1.68 | USD |
Clearside Biomedical Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
99.23M | 62.41M | - | 1.33M | -32.95M | -0.53 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Clearside Biomedical News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLSD Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.80 | 2.12 | 1.4901 | 1.77 | 928,176 | -0.11 | -6.11% |
1 Month | 1.25 | 2.12 | 1.20 | 1.65 | 620,066 | 0.44 | 35.20% |
3 Months | 1.05 | 2.12 | 1.02 | 1.52 | 335,662 | 0.64 | 60.95% |
6 Months | 0.86 | 2.12 | 0.650101 | 1.33 | 229,664 | 0.83 | 96.51% |
1 Year | 1.03 | 2.12 | 0.650101 | 1.25 | 184,693 | 0.66 | 64.08% |
3 Years | 2.84 | 7.73 | 0.650101 | 3.45 | 557,586 | -1.15 | -40.49% |
5 Years | 1.50 | 7.73 | 0.56 | 2.82 | 590,956 | 0.19 | 12.67% |
Clearside Biomedical Description
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision. |